Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Article Commentary
Authors: Edwards, Jodi D.a; b; c; d; *
Affiliations: [a] LC Campbell Cognitive Neurology Research Unit, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Toronto, Canada | [b] Heart & Stroke Foundation Canadian Partnership for Stroke Recovery, Toronto, Canada | [c] Institute for Clinical Evaluative Sciences, Sunnybrook Health Sciences Centre, Toronto, Canada | [d] Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada
Correspondence: [*] Correspondence to: Jodi Edwards, PhD, Affiliate Investigator, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Post-Doctoral Fellow, Canadian Partnership for Stroke Recovery, Institute for Clinical Evaluative Sciences, Sunnybrook Health Sciences Centre, M6, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada. Tel.: +416 480 6100; Fax: +416 480 4223; E-mail: jodi.edwards@sunnybrook.ca.
Abstract: Multiple cardiac pathologies have been shown to contribute to progressive cognitive decline and dementia in elderly populations, including left ventricular hypertrophy (LVH), a marker of prolonged exposure to hypertension. Although associations between chronic hypertension and cognitive function are thought to be mediated primarily by these end organ effects, there is increasing evidence that early changes in cardiac structure and function, such as LVH, may independently contribute to cognitive decline and impairment. In the current issue of the Journal of Alzheimer’s Disease, Mahinrad and colleagues report important new findings on the association between LVH and cognitive function that are incremental to cardiovascular risk and co-morbidity, including hypertension. Emerging evidence that early changes in cardiac structure and function may independently contribute to cognitive decline in elderly populations has resulted in an increased interest in these preclinical substrates as potential treatment targets for the prevention of cognitive decline and in their putative contributions to the pathogenesis of dementia.
Keywords: Cardiac dysfunction, cognition, hypertension, left ventricular hypertrophy
DOI: 10.3233/JAD-170234
Journal: Journal of Alzheimer's Disease, vol. 58, no. 1, pp. 285-288, 2017
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl